<Disease><Name>GALACTOSIALIDOSIS</Name><Synonym>GOLDBERG SYNDROME; NEURAMINIDASE DEFICIENCY; GALACTOSIALIDOSIS</Synonym><OMIM><Number>256540</Number><URL>http://omim.org/entry/256540</URL></OMIM><Orphanet><Number>351</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=351</URL></Orphanet><Protein><Number>Lysosomal protective protein, lysosomal &#206;&#178;-galactosidase and neuraminidase</Number><URL>http://www.uniprot.org/uniprot/P10619</URL></Protein><ExPASy><Number>3.4.16.5</Number><URL>http://enzyme.expasy.org/EC/3.4.16.5</URL></ExPASy><Gene>20q13.12Detail information to gene locus by the National Center for Biotechnology Information NCBI:

Protective protein for beta-galactosidase (cathepsin A)
</Gene><ICD>E77.1</ICD><Summary>rare ;autosomal recessive ;mutation in the CTSA gene;3 forms: ;- early infantile ;- late infantile ;- juvenile/adult</Summary><Symptoms><symtomp><id>2341</id><symptom>angiokeratoma</symptom><category>CARDIOVASCULAR SYSTEM | SKIN</category></symtomp><symtomp><id>1738</id><symptom>ascites</symptom><category>BODY | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1942</id><symptom>ataxia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2211</id><symptom>blindness, visual loss, visual impairment</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2104</id><symptom>cardiomyopathy</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>1733</id><symptom>cherry-red spot on retinal macula</symptom><category>EYES</category></symtomp><symtomp><id>1761</id><symptom>coarse facial features</symptom><category>HEAD</category></symtomp><symtomp><id>2448</id><symptom>corneal clouding</symptom><category>EYES</category></symtomp><symtomp><id>2124</id><symptom>corneal deposits</symptom><category>EYES</category></symtomp><symtomp><id>2227</id><symptom>dysmorphism / dysmorphic features</symptom><category>HEAD</category></symtomp><symtomp><id>2302</id><symptom>dysostosis multiplex</symptom><category>SKELATAL DEFECT</category></symtomp><symtomp><id>2216</id><symptom>edema</symptom><category>SKIN</category></symtomp><symtomp><id>3162</id><symptom>emphysema</symptom><category>LUNG OR RESPIRATORY SYSTEM</category></symtomp><symtomp><id>1882</id><symptom>growth retardation, poor growth</symptom><category>GENERAL TOPICS | GENERAL TOPICS</category></symtomp><symtomp><id>2433</id><symptom>hearing defect, deafness</symptom><category>EARS | NERVOUS SYSTEM</category></symtomp><symtomp><id>2449</id><symptom>heart involvement</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>3342</id><symptom>hemangioma</symptom><category>SKIN</category></symtomp><symtomp><id>1994</id><symptom>hepatomegaly (large liver)</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2356</id><symptom>hydrops fetalis</symptom><category>GENERAL TOPICS | IMMUNE OR HEMATOLOGIC SYSTEM</category></symtomp><symtomp><id>1910</id><symptom>inguinal hernia</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2304</id><symptom>joint stiffness</symptom><category>SKELETAL DEFECT</category></symtomp><symtomp><id>1887</id><symptom>macrocephaly (large calvaria, &gt;2 SD for age)</symptom><category>HEAD</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1900</id><symptom>myoclonus</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2506</id><symptom>onset, adolescent / adolescence</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>3778</id><symptom>pain, extremities (acroparesthesia)</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>2342</id><symptom>skeletal changes, skeletal abnormalities</symptom><category>SKELATAL DEFECT | SKELETAL DEFECT</category></symtomp><symtomp><id>2042</id><symptom>splenomegaly (large spleen)</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2445</id><symptom>teleangiectasia</symptom><category>CARDIOVASCULAR SYSTEM | SKIN</category></symtomp></Symptoms><Metabolites><metabolite><id>890</id><name>beta-Galactosidase</name><specimen>fibroblasts</specimen><value>decreased</value><min>    </min><max>100.00</max><unit>% activity</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>891</id><name>beta-Galactosidase</name><specimen>leucocytes</specimen><value>decreased</value><min>    </min><max>100.00</max><unit>% activity</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>892</id><name>Neuraminidase</name><specimen>fibroblasts</specimen><value>decreased</value><min>    </min><max>100.00</max><unit>% activity</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>893</id><name>Neuraminidase</name><specimen>leucocytes</specimen><value>decreased</value><min>    </min><max>100.00</max><unit>% activity</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>965</id><name>Oligosaccharides</name><specimen>urine</specimen><value>increased</value><min>    </min><max>    </max><unit>not detectable</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1096</id><name>Protein</name><specimen>urine</specimen><value>increased</value><min>50.00</min><max>80.00</max><unit>mg/24 hr</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>889</id><name>Sialyloligosaccharides</name><specimen>urine</specimen><value>increased</value><min>    </min><max>    </max><unit>no data</unit><age>child</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>6408</id><title>Quantitative natural history characterization in a cohort of 142 published cases of patients with galactosialidosis-A cross-sec</title><author>Slama T,</author><journal>J Inherit Metab Dis</journal><year>2018</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>4518</id><title>A Turkish case of galactosialidosis with a new homozygous mutation in CTSA gene</title><author>Kartal A,</author><journal>Metab Brain Dis</journal><year>2017</year><book /><volume>32</volume><number>4</number><pages>973-975</pages><co_aut>Ayd&#305;n K</co_aut></literature><literature><id>4519</id><title>Galactosialidosis: historic aspects and overview of investigated and emerging treatment options</title><author>Annunziata I,</author><journal>Expert Opin Orphan Drugs</journal><year>2017</year><book /><volume>5</volume><number>2</number><pages>131-141</pages><co_aut>dAzzo A</co_aut></literature><literature><id>4520</id><title>Chemical chaperone treatment for galactosialidosis: Effect of NOEV on &#946;-galactosidase activities in fibroblasts</title><author>Hossain MA,</author><journal>Brain Dev</journal><year>2016</year><book /><volume>38</volume><number>2</number><pages>175-180</pages><co_aut>et al.</co_aut></literature><literature><id>4521</id><title>Clinical utility of whole-exome sequencing in rare diseases: Galactosialidosis</title><author>Prada CE,</author><journal>Eur J Med Genet</journal><year>2014</year><book /><volume>57</volume><number>7</number><pages>339-344</pages><co_aut>et al.</co_aut></literature><literature><id>4522</id><title>Galactosialidosis: review and analysis of CTSA gene mutations</title><author>Caciotti A,</author><journal>Orphanet J Rare Dis</journal><year>2013</year><book /><volume>8</volume><number>0</number><pages>114</pages><co_aut>et al.</co_aut></literature><literature><id>4523</id><title>Emphysema in an adult with galactosialidosis linked to a defect in primary elastic fiber assembly</title><author>Lehman A,</author><journal>Mol Genet Metab</journal><year>2012</year><book /><volume>106</volume><number>1</number><pages>99-103</pages><co_aut>et al.</co_aut></literature><literature><id>1780</id><title>The expanding spectrum of disorders with elevated plasma chitotriosidase activity: an update</title><author>Michelakakis H</author><journal>J Inherit Metab Dis</journal><year>2004</year><book /><volume>27</volume><number>5</number><pages>705-706</pages><co_aut>Dimitriou E, Labadaridis I</co_aut></literature><literature><id>155</id><title>Galactosialidosis</title><author>dAzzo A</author><journal>The metabolic and molecular bases of inherited disease, 7/e; Editors: C.R.Scriver, A.L.Beaudet, W.S.Sly, D.Valle; McGraw-Hill Inc.</journal><year>1995</year><book /><volume>2</volume><number>91</number><pages>2825-2837</pages><co_aut>Andria G, Strisciuglio P, Galjaard H</co_aut></literature></Literatures></Disease>